ArticleRadiology. Imaging cancer2026
Arterial-Washout Temporal Profiling in CEUS LI-RADS: A Diagnostic Algorithm for Reducing Hepatocellular Carcinoma Misclassification.
Article in Radiology. Imaging cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Contrast-enhanced ultrasound for precise differentiation of hepatitis-related intrahepatic cholangiocarcinoma and hepatocellular carcinoma.Abdominal radiology (New York) · 2026Review
- CEUS-based quantitative analysis of washout time in focal liver lesions affects hepatocellular carcinoma diagnosis.Quantitative imaging in medicine and surgery · 2026Article
- Fast Times at CEUS High: Rethinking Washout in LI-RADS.Radiology. Imaging cancer · 2026Article
Corrections and comments
- Commented on by
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose To determine whether combining the arterial phase onset time to washout onset time interval (AWTI) with washout onset time improves the accuracy of contrast-enhanced US (CEUS) Liver Imaging Reporting and Data System (LI-RADS) and reduces the incidence of hepatocellular carcinoma (HCC) being misclassified as LR-M. Materials and Methods CEUS and clinical data from patients with focal liver lesions (FLLs), collected between January 2019 and October 2024, were retrospectively analyzed. The AWTI was calculated for all FLLs with washout < 60 seconds. A revised classification was proposed:
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.